Showing results (81-90 of 272) with videos related to

Sort By:
Pageof 28
Transfusion|January 10, 2026
Survey of quality control testing practices on low titer group O whole blood in the United StatesMark H Yazer, Skye Clayton, Christine M Leeper, et al.
Vox Sanguinis|October 23, 2025
RhD-negative red blood cell use and conservation strategies in the Region of Southern DenmarkEmil Ainsworth Jochumsen, Kjell E Titlestad, Ulrik Sprogøe, et al.
Transfusion|March 19, 2024
Survey of policies at US hospitals on the selection of RhD type of low-titer O whole blood for use in trauma resuscitationSkye Clayton, Christine M Leeper, Mark H Yazer, et al.
Transfusion|June 2, 2020
Performance characteristics of thromboelastometry assays using incompletely filled and prolonged stored samplesHelene M Paarup, Mads H Rasmussen, Mark H Yazer, et al.
Transfusion|April 2, 2021
Survey of group A plasma and low-titer group O whole blood use in trauma resuscitation at adult civilian level 1 trauma centers in the USMark H Yazer, Philip C Spinella, Vincent Anto, et al.
Transfusion|June 26, 2022
Attitudes of American adult women toward accepting RhD-mismatched transfusions in bleeding emergenciesGabriel Yu, Jeffrey Siegler, Jane Hayes, et al.
Nagoya Journal of Medical Science|November 2, 2020
Heparin concentration in cell salvage during heparinization: a pilot studyTakahiro Tamura, Jonathan H Waters, Kimitosi Nishiwaki
Transfusion|July 16, 2021
Rate of RhD-alloimmunization after the transfusion of multiple RhD-positive primary red blood cell-containing productsMark H Yazer, Darrell J Triulzi, Jason L Sperry, et al.
Transfusion|February 6, 2019
International assessment of massive transfusion protocol contents and indications for activationReggie R Thomasson, Mark H Yazer, James D Gorham, et al.
Transfusion|July 1, 2005
Amino-acid substitution in the disordered loop of blood group B-glycosyltransferase enzyme causes weak B phenotypeMark H Yazer, Greg A Denomme, Natisha L Rose, et al.
Pageof 28